A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of observational data, to improve clinical outcomes. Ventura A. Simonovich discusses the differences observed in clinical status between patients treated with convalescent plasma and those who received placebo.

Report Infringement

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Hepatic VLDL secretion: DGAT1 determines particle size but not particle number

Next Article

School bullying: Teachers helping students cope

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×